NCT07503405Phase 2Not yet recruiting

Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model

Study sponsor: Traws Pharma, Inc. · TRAW

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-11Estimated
Enrollment · participants165Estimated
Source updated2026-03-31Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.